Glenmark cuts kidney cancer drug cost by 96%
India-based pharmaceuticals maker Glenmark Pharma has launched a generic version of a popular kidney cancer drug priced 96% lower than the branded version in India. Pfizer is the innovator of Sunitinib. Glenmark said its drug is launched at a price that is approximately 96% lower than the MRP of the innovator brand. Glenmark’s prices are […]